Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Art v 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.9 - Pollen Allergy2014Czech RepublicIgE82613.60020140606, Panzner P
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE762.60020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE358.57020130605, Simon D
1.4 - Respiratory Symptoms, Diagnosed2013GermanyIgE103912.30020130805, Boehme MW
1.4 - Respiratory Symptoms, Diagnosed2013SpainIgE1872.70020131016, Feliu A
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14011.43020130111, Ott H
4.1.3 - Heterologous Source Sensitized (SPT)2013ItalyIgE1711.76020131031, Bonura A
5.3.1 - Source Exposed (Symptoms, IgE)2013ChinaIgE1788.24020130510, Ma S
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE969.38020120528, Patelis A
1.4 - Respiratory Symptoms, Diagnosed2012FranceIgE12931.80020121204, Caimmi D
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5418.50020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE263.80020120310, Twaroch TE
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE2338.60020120726, Flores E
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE993.03020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2012ChinaIgE6177.05020120903, Gao ZS
6.2 - General Population (Adults)2012SwedenIgE3713.23020120528, Patelis A
1.4 - Respiratory Symptoms, Diagnosed2011SpainIgE6813.20020110509, Rodriguez D
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1004.00020111214, Zheng YW
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE868.13920101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164084.09020100301, Scala E
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010ChinaIgE1788.25020101229, Han D
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010ChinaIgE1376.92020101229, Han D
5.3.1 - Source Exposed (Symptoms, IgE)2010ChinaIgE4481.81020101229, Han D
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2060.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE375.40520090826, Ebo DG
1.4 - Respiratory Symptoms, Diagnosed2008SpainIgE78612.47020081010, Barber D
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2008SpainIgE5035.00020080413, Luengo O
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2008CanadaIgE1040.00020081010, Gadermaier G
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaIgE988.89020081010, Gadermaier G
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2007GermanyIgE10079.00020070912, Oberhuber C
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007SpainSPT1973.70020070524, Arilla MC
5.6.1 - Source Exposed (IgE)2004SpainIgE4479.00020040813, Jimeno L
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2003SwitzerlandIgE32100.00020030623, Schmid-Grendelmeier P
3.2.1 - Source Sensitized (IgE)2002NetherlandsIgE5590.0002002, Himly M
Developed by
Panservice